drugset / Trial / NCT03330132

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong

NCT03330132

RandomizedParallel-groupTriple-blindPrevention

Summary

This study allows to evaluate the strength and duration of immune responses between annual receipt of standard inactivated vaccine and alternative potent vaccines, including annual receipt of adjuvanted inactivated vaccine, annual receipt of high-dose inactivated vaccine, annual receipt of recombinant HA vaccine, and the alternate combinations of the former three vaccines over four years, for identifying improved vaccination strategies for influenza vaccination in older adults in a location experiencing a subtropical pattern in influenza activity.

Timeline

Start
2017-10-07
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject FLUAD Vaccine 0.5 ml
Subject FluQuadri Vaccine 0.5 ml
Subject Flublok Vaccine 0.5 ml
Subject Influenza Virus Vaccine Vaccine 0.5 ml

Indications